Skip to main content

Table 2 Comparison of characteristics of lung cancer among the CPFE, IPF-alone, and emphysema-alone groups

From: An autopsy study of combined pulmonary fibrosis and emphysema: correlations among clinical, radiological, and pathological features

 

CPFE

IPF

Emphysema

 
 

(n = 22)

(n = 8)

(n = 17)

p-value

Patients with lung cancer

19 (86.4%)

1 (12.5%)

17 (100%)

<0.001

Histology of lung cancer

    

Adenocarcinoma

8 (42.1%)

0

9 (52.9%)

0.523

Squamouse cell carcinoma

8 (42.1%)

0

4 (23.5%)

0.386

Large cell carcinoma

1 (5.2%)

0

0

0.615

Small cell carcinoma

4 (21.1%)

1 (12.5%)

4 (23.5%)

0.199

Primary site

    

Upper lobe

9 (47.4%)

0

8 (47.0%)

0.646

Lower lobe

9 (47.4%)

1 (12.5%)

9 (52.9%)

0.581

Clinical stage

    

IA

0

0

0

-

IB

2 (11.8%)

0

3 (20%)

0.76

IIA

0

0

2 (13.3%)

0.288

IIB

2 (11.8%)

0

0

0.367

IIIA

2 (11.8%)

1 (12.5%)

0

0.002

IIIB

2 (11.8%)

0

3 (20%)

0.76

IV

10 (58.8%)

0

7 (46.7%)

0.51

Treatment for lung cancer

    

Surgery

1 (5.9%)

0

3 (18.8%)

0.46

Chemotherapy

13 (76.5%)

0

6 (37.5%)

0.081

Radiation

2 (11.8%)

0

7 (43.8%)

0.086

Best supportive care only

5 (29.4%)

1 (12.5%)

5 (31.3%)

0.291

  1. Values are the mean ± standard deviation.
  2. IPF, idiopathic pulmonary fibrosis.
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us